Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dina Navia-Paldanius

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD6Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD12Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Journal of Lipid Research|September 13, 2012
Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)Dina Navia-Paldanius, Juha R Savinainen, Jarmo T Laitinen
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 14, 2015
Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipaseDina Navia-Paldanius, Niina Aaltonen, Marko Lehtonen, et al.
Plos One|October 8, 2014
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A)Juha R Savinainen, Jayendra Z Patel, Teija Parkkari, et al.
Bioorganic & Medicinal Chemistry|September 8, 2015
Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 InhibitorsJayendra Z Patel, John van Bruchem, Tuomo Laitinen, et al.
Molecular Pharmacology|December 26, 2013
Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potencyTuomo Laitinen, Dina Navia-Paldanius, Roosa Rytilahti, et al.
Bioorganic & Medicinal Chemistry|October 6, 2014
Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL)Jani Korhonen, Anne Kuusisto, John van Bruchem, et al.
Molecular Pharmacology|August 21, 2014
Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL)Juha R Savinainen, Emilia Kansanen, Tatu Pantsar, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2016
In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD6Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD12Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Journal of Lipid Research|September 13, 2012
Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)Dina Navia-Paldanius, Juha R Savinainen, Jarmo T Laitinen
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 14, 2015
Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipaseDina Navia-Paldanius, Niina Aaltonen, Marko Lehtonen, et al.
Plos One|October 8, 2014
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A)Juha R Savinainen, Jayendra Z Patel, Teija Parkkari, et al.
Bioorganic & Medicinal Chemistry|September 8, 2015
Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 InhibitorsJayendra Z Patel, John van Bruchem, Tuomo Laitinen, et al.
Molecular Pharmacology|December 26, 2013
Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potencyTuomo Laitinen, Dina Navia-Paldanius, Roosa Rytilahti, et al.
Bioorganic & Medicinal Chemistry|October 6, 2014
Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL)Jani Korhonen, Anne Kuusisto, John van Bruchem, et al.
Molecular Pharmacology|August 21, 2014
Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL)Juha R Savinainen, Emilia Kansanen, Tatu Pantsar, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2016
In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, et al.
Pageof 2